Neutrophils as Main Players of Immune Response Towards Nondegradable Nanoparticles.

NETs nano/microparticles (nµP) nanoparticle (nP) neutrophil plasma membrane tubular structures

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
29 Jun 2020
Historique:
received: 12 06 2020
revised: 25 06 2020
accepted: 25 06 2020
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 3 7 2020
Statut: epublish

Résumé

Many nano/microparticles (n/µP), to which our body is exposed, have no physiological way of removal. Our immune system sense these "small particulate objects", and tries to decrease their harmfulness. Since oxidation, phagocytosis and other methods of degradation do not work with small, chemically resistant, and hydrophobic nanoparticles (nP). This applies to soot from air pollution, nano-diamonds from cosmic impact, polishing and related machines, synthetic polymers, and dietary n/µP. Our body tries to separate these from the surrounding tissue using aggregates from neutrophil extracellular traps (NETs). This effectively works in soft tissues where n/µP are entrapped into granuloma-like structures and isolated. The interactions of hydrophobic nanocrystals with circulating or ductal patrolling neutrophils and the consequent formation of occlusive aggregated NETs (aggNETs) are prone to obstruct capillaries, bile ducts in gallbladder and liver, and many more tubular structures. This may cause serious health problems and often fatality. Here we describe how specific size and surface properties of n/µP can activate neutrophils and lead to aggregation-related pathologies. We discuss "natural" sources of n/µP and those tightly connected to unhealthy diets.

Identifiants

pubmed: 32610567
pii: nano10071273
doi: 10.3390/nano10071273
pmc: PMC7408411
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 861878
Organisme : Horizon 2020 Framework Programme
ID : 872331
Organisme : Volkswagen Foundation
ID : 97744
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1181 projects: C03, A01, B02, and Z02; KFO 306; FOR 2886 projects: A03, B03, and B04
Organisme : Ministry of Healthcare of Ukraine
ID : 0119U101338
Organisme : RECOOP HST Association (Cedars Sinai Medical Center's International Research and Innovation in Medicine Program, the Association for Regional Cooperation in the Fields of Health, Science and Technology)
ID : RCSS 020, and BMYSRG 015

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

NPJ Vaccines. 2017 Jan 23;2:1
pubmed: 29263862
Acta Med Scand Suppl. 1972;542:111-4
pubmed: 4579747
Front Immunol. 2016 Oct 10;7:424
pubmed: 27777576
Science. 2017 Dec 1;358(6367):1202-1206
pubmed: 29191910
J Biosci Bioeng. 2013 Jun;115(6):674-9
pubmed: 23428334
J Clin Invest. 1968 May;47(5):1043-52
pubmed: 5645851
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
RMD Open. 2015 Aug 15;1(Suppl 1):e000046
pubmed: 26557370
Front Pharmacol. 2020 Jun 05;11:870
pubmed: 32581816
Antioxid Redox Signal. 2013 Feb 20;18(6):642-60
pubmed: 22881869
Autoimmunity. 2010 Apr;43(3):236-8
pubmed: 20187703
Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1486-9
pubmed: 24364949
J Biomed Nanotechnol. 2012 Jun;8(3):522-7
pubmed: 22764423
J Am Soc Nephrol. 2019 Oct;30(10):1857-1869
pubmed: 31296606
J Hepatol. 2018 May;68(5):1063-1075
pubmed: 29408694
Autoimmunity. 2018 Sep;51(6):297-303
pubmed: 30369266
Nat Commun. 2016 Jan 28;7:10274
pubmed: 26817517
Nat Commun. 2016 Mar 11;7:10973
pubmed: 26964500
Nat Rev Microbiol. 2007 Aug;5(8):577-82
pubmed: 17632569
ACS Nano. 2015;9(4):3704-20
pubmed: 25840649
Front Immunol. 2017 Jul 28;8:874
pubmed: 28804484
Nutrients. 2017 Apr 18;9(4):
pubmed: 28420204
Internist (Berl). 2006 May;47(5):509-20; quiz 521
pubmed: 16586130
Front Immunol. 2016 Dec 01;7:557
pubmed: 27990145
Ann Rheum Dis. 1986 Oct;45(10):873-7
pubmed: 3789822
Nat Rev Nephrol. 2019 Sep;15(9):559-575
pubmed: 31213698
Nutrition. 2014 Jul-Aug;30(7-8):928-35
pubmed: 24985013
J Biol Chem. 2011 Jan 7;286(1):35-41
pubmed: 21051542
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5856-E5865
pubmed: 27647892
Immunity. 2019 Sep 17;51(3):443-450.e4
pubmed: 31422870
Front Immunol. 2019 Apr 17;10:844
pubmed: 31057557
Sci Rep. 2017 Nov 3;7(1):15003
pubmed: 29101355
Blood. 1997 May 15;89(10):3503-21
pubmed: 9160655
Curr Rheumatol Rep. 2014 Feb;16(2):400
pubmed: 24357445
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401

Auteurs

Rostyslav Bilyy (R)

Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine.

Galyna Bila (G)

Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine.
Institute of Animal Biology NAAS, 79034 Lviv, Ukraine.

Oleg Vishchur (O)

Institute of Animal Biology NAAS, 79034 Lviv, Ukraine.

Volodymyr Vovk (V)

Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine.

Martin Herrmann (M)

Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nurnberg (FAU), Universitatsklinikum Erlangen, 90154 Erlangen, Germany.

Classifications MeSH